Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat

Biopharmaceutics and Drug Disposition

Volumn 20, Issue 3, 1999, Pages 151-158

  Sasabe, Hiroyuki ^a   Kato, Yukio ^a   Terasaki, Tetsuya ^b   Tsuji, Akira ^c   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Grepafloxacin; Hepatobiliary transport; Lomefloxacin; Quinolone antibiotics

Indexed keywords

GREPAFLOXACIN; LOMEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG TRANSPORT; DRUG UPTAKE; HEPATOBILIARY SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LIVER BLOOD FLOW; LIVER CELL; LIVER CLEARANCE; MALE; MEMBRANE TRANSPORT; NONHUMAN; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; BILIARY TRACT; BIOLOGICAL TRANSPORT; CELLS, CULTURED; FLUOROQUINOLONES; LIVER; MALE; PIPERAZINES; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033060547     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199904)20:3<151::AID-BDD168>3.0.CO;2-P     Document Type: Article

References (30)

1. Akiyama H, Koike M, Kyuushiki K, Suzuki T, Kusumoto N, Morita S and Odomi M. Pharmacokinetics of grepafloxacin (IV): metabolism after oral administration of grepafloxacin in rats, monkeys and humans. Chemotherapy 1995; 43: 131-149.
2. Sasabe H, Terasaki T, Tsuji A and Sugiyama Y. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat. J Pharmacol Exp Ther 1997; 282: 162-171.
3. Mikami T, Nozaki T, Tagaya O, Hosokawa S, Nakura T, Mori H and Kondou S. The characters of a new mutant in rats with hyperbilirubinemic syndrome. Cong Anom 1986; 26: 250-251.
4. Huber M, Guhlmann A, Jansen PLM and Keppler D. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology 1987; 7: 224-228.
5. Ishikawa T, Müller M, Klünemann C, Schaub T and Keppler D. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. J Biol Chem 1990; 265: 19279-19286.
6. Fernandez-Checa JC, Takikawa H, Horie T, Ookhtens M and Kaplowitz N. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J Biol Chem 1992; 267: 1667-1673.
7. Sathirakul K, Suzuki H, Yasuda K, Hanano M, Tagaya O, Horie T and Sugiyama Y. Multiple transport systems for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 1993; 268: 65-73.
8. Shimamura H, Suzuki H, Hanano M, Suzuki A, Tagaya O, Horie T, Sugiyama Y, Suzuki H, Iga T and Hanano M. Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds. J Pharmacol Exp Ther 1994; 271: 370-378.
9. Takenaka O, Horie T, Suzuki H, Kobayashi K and Sugiyama Y. Kinetic analysis of hepatobiliary transport for conjugative metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugative hyperbilirubinemia. Pharm Res 1995; 12: 1746-1755.
10. Takenaka O, Horie T, Suzuki H and Sugiyama Y. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai Hyperbilirubinemic rats. J Pharmacol Exp Ther 1995; 274: 1362-1369.
11. Yamazaki M, Suzuki H, Hanano M, Tokui T, Komai T and Sugiyama Y. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotks. Pharm Res 1996; 13: 497-513.
12. Chu XY, Kato Y, Niinuma K, Sudo K, Hakusui H and Sugiyama Y. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. J Pharmacol Exp Ther 1997; 281: 304-314.
13. Sasabe H, Terasaki T, Tsuji A and Sugiyama Y. Carrier-mediated mechanism for the biliary excretion of a quinolone antibiotics, grepafloxacin and its glucuronide in the rat. J Pharmacol Exp Ther 1998; 284: 1033-1039.
14. Baur H, Kasperek S and Pfaff E. Criteria of viability of isolated liver cells. Hoppe-Seyler's Z PhysiolChem 1975; 356: 827-838.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
16. Schwenk M. Transport systems of isolated hepatocytes: Studies on the transport of biliary compounds. Arch Toxicol 44: 113-126.
17. Kim DC, Sugiyama Y, Satoh H, Fuwa T, Iga T and Hanano M. Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J Pharm Sci 1988; 77: 200-207.
18. Yanai M, Sugiyama Y, Iga T, Fuwa T and Hanano M. Kinetic analysis of the downregulation of epidermal growth factor receptors in rats in vivo. Am J Physiol 1990; 258: C593-C598.
19. 14C]-grepafloxacin in rats. Chemotherapy 1995; 43: 107-124.
20. Okezaki E, Terasaki T, Nakamura M, Nagata O, Kato H and Tsuji A. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, new antimicrobial agent, and the related pyridone carboxylic acids. Drug Metab Dispos 1988; 16: 865-874.
21. 14C]-DL-8280 in various animal species. Chemotherapy 1984; 32: 1203-1209.
22. Okezaki E, Oomichi K, Koike S, Takahashi Y, Makino E, Terasaki T and Tsuji A. Bioassay study of absorption, distribution and excretion of NY-198 compared with norfloxacin and ofloxacin. Chemotherapy 1988; 36: 188-193.
23. 14C-Sparfloxacin in the rat. Arzneim-Forsch/Drug Res 1991; 41: 747-759.
24. Dedrick RL, Zaharko DS and Lutz RJ. Transport and binding of methotrexate in vivo. J Pharm Sci 1973; 62: 882-890.
25. Luts RJ, Dedrick RL, Matthew HB, Eling TE and Anderson MW. A preliminary pharmacokinetic model for several chlorinated biphenyls in rat. Drug Metab Dispos 1977; 5: 386-396.
26. Tsuji A, Yoshikawa T, Nishide K, Minami H, Kimura M, Nakashima E, Terasaki T, Miyamoto E, Nightingale CH and Yamana T. Physiologically based pharmacokinetic model for b-lactam antibiotics I: Tissue distribution and elimination in rats. J Pharm Sci 1983; 72: 1239-1252.
27. Sasabe H, Kato Y, Tsuji A and Sugiyama Y. Stereoselective hepatobiliary transport of the quinolone antibiotic, grepafloxacin and its glucuronide in the rat. J Pharmacol Exp Ther 1998; 284, 661-668.
28. Yamazaki M, Suzuki H, Sugiyama Y, Iga T and Hanano M. Uptake of organic anions by isolated rat hepatocytes: a classification in terms of ATP-dependency. J Hepatol 1992; 14: 41-47.
29. Ichikawa M, Tsao SC, Lin TH, Miyauchi S, Sawada Y, Iga T, Hanano M and Sugiyama Y. Albumin-mediated transport phenomenon observed for ligands with membrane permeability: Effect of the unstirred water layer in the Disse's space of rat liver. J Hepatol 1992; 16: 38-49.
30. Miyauchi S, Sawada Y, Iga T, Hanano M and Sugiyama Y. Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers. Pharm Res 1993; 10: 434-440.